Successful delivery of docetaxel to rat brain using experimentally developed nanoliposome: a treatment strategy for brain tumor

References

• Akbarzadeh A, Rezaei-Sadabady R, Davaran S, et al. (2013). Liposome: classification, preparation, and applications. Nanoscale Res Lett 8:102.
   PubMed Web of Science ®Google Scholar
• Allen TM, Moase EH. (1996). Therapeutic opportunities for targeted liposomal drug delivery. Adv Drug Deliv Rev 21:117–33.
   Web of Science ®Google Scholar
• Asperen JA, Mayer U, Tellingen OV, et al. (1997). The functional role of p-glycoprotein in the blood–brain barrier. J Pharm Sci 86:881–4.
   PubMed Web of Science ®Google Scholar
• Baishya R, Nayak DK, Sinha S. (2016). Ursolic acid loaded PLGA nanoparticles: in vitro and in vivo evaluation to explore tumor targeting ability on B16F10 melanoma cell lines. Pharm Res 33:2691–703.
   PubMed Web of Science ®Google Scholar
• Banks WA. (2009). Characteristics of compounds that cross the blood–brain barrier. BMC Neurol 9:S3.
   PubMed Web of Science ®Google Scholar
• Barth RF. (1998). Rat brain tumor models in experimental neuro-oncology: the 9L, C6, T9, F98, RG2 (D74), RT-2 and CNS-1 gliomas. J Neurooncol 36:91–102.
   PubMed Web of Science ®Google Scholar
• Beaulieu E, Demeule M, Ghitescu L, et al. (1997). P-glycoprotein is strongly expressed in the luminal membranes of the endothelium of blood vessels in the brain. Biochem J 326:539–44.
   PubMed Web of Science ®Google Scholar
• Chang HI, Yeh MK. (2012). Clinical development of liposome-based drugs: formulation, characterization, and therapeutic efficacy. Int J Nanomedicine 7:49–60.
   PubMed Web of Science ®Google Scholar
• Chen Y, Dalwadi G, Benson HA. (2004). Drug delivery across the blood–brain barrier. Curr Drug Deliv 1:361–76.
   PubMedGoogle Scholar
• Costantino L, Boraschi D. (2012). Is there a clinical future for polymeric nanoparticles as brain–targeting drug delivery agents? Drug Discov Today 17:367–78.
   PubMed Web of Science ®Google Scholar
• Dey G, Bharti R, Dhanarajan G, et al. (2015). Marine lipopeptide Iturin A inhibits Akt mediated GSK3β and FoxO3a signaling and triggers apoptosis in breast cancer. Sci Rep 5:10316.
   PubMed Web of Science ®Google Scholar
• Dey NS, Mukherjee B, Maji R, et al. (2016). Development of linker-conjugated nanosize lipid vesicles: a strategy for cell selective treatment in breast cancer. Curr Cancer Drug Targets 16:357–72.
   PubMed Web of Science ®Google Scholar
• Dou J, Zhanga H, Liub X, et al. (2014). Preparation and evaluation in vitro and in vivo of docetaxel loaded mixed micelles for oral administration. Colloids Surf B Biointerfaces 114:20–7.
   PubMed Web of Science ®Google Scholar
• Guo J, Gao X, Su L, et al. (2011). Aptamer-functionalized PEG-PLGA nanoparticles for enhanced anti-glioma drug delivery. Biomaterials 32:8010–20.
   PubMed Web of Science ®Google Scholar
• Hao Y, Wang L, Zhao Y, et al. (2015). Targeted imaging and chemo-phototherapy of brain cancer by a multifunctional drug delivery system. Macromol Biosci 15:1571–85.
   PubMed Web of Science ®Google Scholar
• Helvig S, Azmi IDM, Moghimi SM, et al. (2015). Recent advances in cryo-TEM imaging of soft lipid nanoparticles. AIMS Biophysics 2:116–30.
   Web of Science ®Google Scholar
• Hou W, Watters JW, McLeod HL. (2004). Simple and rapid docetaxel assay in plasma by protein precipitation and high-performance liquid chromatography-tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 804:263–7.
   PubMed Web of Science ®Google Scholar
• Hu K, Cao S, Hu F, et al. (2012). Enhanced oral bioavailability of docetaxel by lecithin nanoparticles: preparation, in vitro, and in vivo evaluation. Int J Nanomedicine 7:3537–45.
   PubMed Web of Science ®Google Scholar
• Irache JM, Esparza I, Gamazo C, et al. (2011). Nanomedicine: novel approaches in human and veterinary therapeutics. Vet Parasitol 180:47–71.
   PubMed Web of Science ®Google Scholar
• Jain KK. (2012). Nanobiotechnology-based strategies for crossing the blood–brain barrier. Nanomedicine (Lond) 7:1225–33.
   PubMed Web of Science ®Google Scholar
• Kemper EM, Verheij M, Boogerd W, et al. (2004). Improved penetration of docetaxel into the brain by co-administration of inhibitors of P-glycoprotein. Eur J Cancer 40:1269–74.
   PubMed Web of Science ®Google Scholar
• Kobayashi H, Watanabe R, Choyke PL. (2014). Improving conventional enhanced permeability and retention (EPR) effects; what is the appropriate target? Theranostics 4:81–9.
   Web of Science ®Google Scholar
• Kuppens IE, van Maanen MJ, Rosing H, et al. (2005). Quantitative analysis of docetaxel in human plasma using liquid chromatography coupled with tandem mass spectrometry. Biomed Chromatogr 19:355–61.
   PubMed Web of Science ®Google Scholar
• Laouini A, Jaafar-Maalej C, Limayem-Blouza I, et al. (2012). Preparation, characterization and applications of liposomes: state of the art. J Colloid Sci Biotechnol 1:147–68.
   Google Scholar
• Liu Z, Liu D, Wang L, et al. (2011). Docetaxel-loaded pluronic P123 polymeric micelles: in vitro and in vivo evaluation. Int J Mol Sci 12:1684–96.
   PubMed Web of Science ®Google Scholar
• MacLachlan I. (2007). Liposomal formulations for nucleic acid delivery. In: Stanley T. Crooke, ed. Antisense drug technology: principles: strategies, and applications. Taylor and Francis Group, LLC: London, 2007; 253–54.
   Google Scholar
• Masserini M. (2013). Nanoparticles for brain drug delivery. ISRN Biochem 2013:1–18.
   Google Scholar
• Mukherjee B, Mondal L, Chakraborty S, et al. (2015). Size dependent variations of phospholipid based vesicular drug carriers in systemic drug activity. Curr Pharm Biotechnol 16:380–91.
   PubMed Web of Science ®Google Scholar
• Nance E, Zhang C, Shih TY, et al. (2014). Brain-penetrating nanoparticles improve paclitaxel efficacy in malignant glioma following local administration. ACS Nano 8:10655–64.
   PubMed Web of Science ®Google Scholar
• Pattnaik G, Sinha B, Mukherjee B, et al. (2012). Submicron-size biodegradable polymer-based didanosine particles for treating HIV at early stage: an in vitro study. Microencapsulation 29:666–76.
   PubMed Web of Science ®Google Scholar
• Sanchez-Moreno P, Boulaiz H, Ortega-Vinuesa JL, et al. (2012). Novel drug delivery system based on docetaxel-loaded nanocapsules as a therapeutic strategy against breast cancer cells. Int J Mol Sci 13:4906–19.
   PubMed Web of Science ®Google Scholar
• Shilo M, Sharon A, Baranes K, et al (2015). The effect of nanoparticle size on the probability to cross the blood-brain barrier: an in-vitro endothelial cell model. J Nanobiotechnology 13:1–7.
   PubMed Web of Science ®Google Scholar
• Sinha B, Mukherjee B, Pattnaik G. (2013). Poly-lactide-co-glycolide nanoparticles containing voriconazole for pulmonary delivery: in vitro and in vivo study. Nanomedicine 9:94–104.
   PubMed Web of Science ®Google Scholar
• Sonali S, Singh RP, Singh N, et al. (2016a). Transferrin liposomes of docetaxel for brain targeted cancer applications: formulation and brain theranostics. Drug Deliv 23:1261–71.
   PubMed Web of Science ®Google Scholar
• Sonali S, Agrawal P, Singh RP, et al. (2016c). Transferrin receptor targeted vitamin E TPGS micelles for brain cancer therapy: preparation, characterization and brain distribution in rats. Drug Deliv 23:1788–98.
   PubMed Web of Science ®Google Scholar
• Sonali S, Singh RP, Sharma G, et al. (2016b). RGD-TPGS decorated theranostic liposomes for brain targeted delivery. Colloids Surf B Biointerfaces 147:129–41.
   PubMed Web of Science ®Google Scholar
• Tan Q, Liu X, Fu X, et al. (2012). Current development in nanoformulations of docetaxel. Expert Opin Drug Deliv 9:975–90.
   PubMed Web of Science ®Google Scholar
• Tije AJ, ten Verweij J, Loos WJ, et al. (2003). Pharmacological effects of formulation vehicles : implications for cancer chemotherapy. Clin Pharmacokinet 42:665–85.
   PubMed Web of Science ®Google Scholar
• van Rooy I, Cakir-Tascioglu S, Hennink WE, et al. (2011). In vivo methods to study uptake of nanoparticles into the brain. Pharm Res 28:456–71.
   PubMed Web of Science ®Google Scholar
• Venishetty VK, Komuravelli R, Kuncha M, et al. (2013). Increased brain uptake of docetaxel and ketoconazole loaded folate-grafted solid lipid nanoparticles. Nanomedicine 9:111–21.
   PubMed Web of Science ®Google Scholar
• Venkatesan P, Puvvada N, Dash R, et al. (2011). The potential of celecoxib-loaded hydroxyapatite-chitosan nanocomposite for the treatment of colon cancer. Biomaterials 32:3794–806.
   PubMed Web of Science ®Google Scholar
• Yang T, Cui FD, Choi MK, et al. (2007). Enhanced solubility and stability of PEGylated liposomal paclitaxel: in vitro and in vivo evaluation. Int J Pharm 338:317–26.
   PubMed Web of Science ®Google Scholar
• Yousefi A, Esmaeili F, Rahimian S, et al. (2009). Preparation and in vitro evaluation of a pegylated nano-liposomal formulation containing docetaxel. Sci Pharm 77:453–64.
   Google Scholar
• Zhang L, Zhang N. (2013). How nanotechnology can enhance docetaxel therapy. Int J Nanomedicine 8:2927–41.
   PubMed Web of Science ®Google Scholar